| Nichelle Schloemer, PHARMD | |
|
204 Belknap St, Superior, WI 54880-2900 | |
| (715) 817-7146 | |
| Not Available |
| Full Name | Nichelle Schloemer |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Ambulatory Care |
| Location | 204 Belknap St, Superior, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114693702 | NPI | - | NPPES |
| NA | Other | NA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P2201X | Pharmacist - Ambulatory Care | 122756 (Minnesota) | Secondary |
| 1835P2201X | Pharmacist - Ambulatory Care | 18532 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nichelle Schloemer, PHARMD 204 Belknap St, Superior, WI 54880-2900 Ph: (715) 817-7146 | Nichelle Schloemer, PHARMD 204 Belknap St, Superior, WI 54880-2900 Ph: (715) 817-7146 |
News Archive
Biologists at the University of California, San Diego have succeeded in engineering algae to produce potential candidates for a vaccine that would prevent transmission of the parasite that causes malaria, an achievement that could pave the way for the development of an inexpensive way to protect billions of people from one of the world's most prevalent and debilitating diseases. Initial proof-of-principle experiments suggest that such a vaccine could prevent malaria transmission.
Vanderbilt University Medical Center infectious diseases researchers are launching a trial for a new vaccine against Staphylococcus aureus. The vaccine, if proven effective, could help curb the growing threat of methicillin-resistant Staphylococcus aureus (MRSA), an emerging organism rapidly spreading through close personal contact.
Valeant Pharmaceuticals International, Inc. and Salix Pharmaceuticals, Ltd. today announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Salix for $158.00 per share in cash, or a total enterprise value of approximately $14.5 billion.
Many patients undergoing hip or knee replacement are still taking prescription opioid pain medications up to six months after surgery, reports a study in PAIN, the official publication of the International Association for the Study of Pain.
Healthpoint today announced that the U.S. Food and Drug Administration has granted approval to manufacture commercial supplies of Collagenase SANTYL Ointment, a biologic enzymatic debriding agent, at DPT Laboratories' Center of Excellence for Sterile & Specialty Products facility in Lakewood, New Jersey.
› Verified 1 days ago
Dr. Jason Kerska, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2015 Tower Ave, Superior, WI 54880 Phone: 715-392-9550 | |
Mr. James Francis Sheahan Jr., Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3535 Tower Ave, Superior, WI 54880 Phone: 715-392-9876 Fax: 715-392-9876 | |
Nicholas Fetter, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3015 Tower Ave, Superior, WI 54880 Phone: 715-394-5551 | |
Katherine Adele Haas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3500 Tower Ave, Superior, WI 54880 Phone: 715-817-7100 | |
Kathy Gore, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3705 Tower Ave, Superior, WI 54880 Phone: 715-392-9520 | |
Rodneyt Tester, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2015 Tower Ave, Superior, WI 54880 Phone: 715-392-9550 Fax: 715-392-3724 | |
Nicholas Rickoff, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 Belknap St Ste 100, Superior, WI 54880 Phone: 715-817-7224 Fax: 715-817-7193 |